Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JVRS-100 Adjuvant with Fluzone in Elderly
NCT00936468Phase 2Completed
- Sponsor
- Colby Pharmaceutical Company
- Start
- Sep 2009
- Primary completion
- Jun 2010
- Modality
- Antisense DNA, Vaccines & Immunotherapeutics, Small Interfering RNA (siRNA)
01
Overview
A Phase 2 trial of JVRS-100 in influenza, sponsored by Colby Pharmaceutical Company. Started Sep 2009; status: completed.
02
Drugs
JVRS-100
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00936468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936468.